VPS35 and Parkinson disease: So far, peripheral blood neutrophils and monocytes have been used to demonstrate that PD patients carrying a pathogenic heterozygous VPS35 D620N mutation as well as carriers of the LRRK2 R1441G variant have significantly increased LRRK2-dependent Rab10 phosphorylation levels [74], [75].